Status:

RECRUITING

Analgesic Effects of Combined Nalbuphine-bupivacaine Versus Dexamethasone-bupivacaine in Pericapsular Nerve Group Block (PENG) After Hip Surgeries: A Randomized Clinical Study

Lead Sponsor:

Zagazig University

Conditions:

Analgesia, Postoperative

Eligibility:

All Genders

21-65 years

Phase:

NA

Brief Summary

The aim of the study to Evaluate the efficacy of nalbuphine-bupivacaine vs dexamethasone-bupivacaine in ultrasound guided pericapsular nerve group (PENG) block for improving pain management, reducing ...

Detailed Description

1. To measure the time of first request of rescue analgesia and to assess the total amount of rescue analgesic consumption (pethidine) in the first 24 hours post-operatively in each group. 2. To asses...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Patients acceptance.
  • Age: Adults aged 21-64 years old.
  • BMI: 25-30 kg/m2
  • Sex: both sexes (males or females).
  • Patients undergoing unilateral hip surgery under spinal anesthesia.
  • ASA (American Society of Anesthesiologists) physical status classification I to II.
  • \*Exclusion criteria:
  • Patients with contraindications to regional anesthesia (e.g. local or systemic infections, or severe neurological or muscular disorders or patient on anticoagulant).
  • Allergy to study drugs: bupivacaine or nalbuphine or dexamethasone
  • Patients with severe cardiovascular, respiratory, renal, or hepatic conditions, uncontrolled diabetes diseases, or those undergoing chronic opioid therapy.
  • Psychiatric disorders that hinder informed consent or study participation.
  • history of neurological diseases or conditions that would affect the efficacy of nerve blocks (e.g., neuropathy, spinal cord injury, or history of severe muscle weakness).

Exclusion

    Key Trial Info

    Start Date :

    April 1 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 1 2026

    Estimated Enrollment :

    102 Patients enrolled

    Trial Details

    Trial ID

    NCT06972654

    Start Date

    April 1 2025

    End Date

    January 1 2026

    Last Update

    May 15 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Faculity of medicine, Zagazig university, Zagazig

    Zagazig, Egypt